Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


German industry group sounds a note of cautious optimism

This article was originally published in RAJ Devices

Executive Summary

In its newly published annual report, Germany’s medical devices industry association, BVMed, targets reimbursement and various legislative amendments as its main concerns1. Whereas companies remain upbeat about the rapid access to market for products, it is primarily the low level of reimbursement in Germany compared with other European countries that is eating away at the industry’s confidence. Furthermore, from a legal perspective, the fourth revision to the German Medical Devices Act (MPG)2, the European Commission’s plans for a recast of the medical device directives3 and the last revision of the MDD (ie European Directive 2007/47/EC, the so-called “amending directive”) are also a cause for concern, BVMed maintains.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts